logo
  

IFF To Sell Microbial Control Business Unit To Lanxess For About $1.3 Bln

International Flavors & Fragrances Inc. (IFF) said that it agreed to sell its Microbial Control business unit to Lanxess for about $1.3 billion.

The cash proceeds net of taxes and expenses will be primarily used to reduce outstanding debt, IFF said in a statement.

IFF Microbial Control employs around 270 people and operates two production facilities at its U.S. sites in St. Charles, Louisiana, and Institute, West Virginia.

Lanxess expects the transaction to be completed in the second quarter of 2022. It expects the deal to be earnings per share accretive already in the first fiscal year after closing.

Lanxess noted that it will finance the purchase price with debt capital and has secured respective bridge financing for this purpose.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT